Mark Chin - Director at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Chin since 11/21/2023

Holdings reported by Mark Chin for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.34M $35.5M $15.14 Jun 2, 2022 By entities affiliated with Arix Bioscience plc
Stock Options (Right to Buy) 8.5K Jun 2, 2022 Direct Common Stock

Transactions reported by Mark Chin for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.